These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25114589)

  • 1. Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer.
    Wohlrab J; Bangemann N; Kleine-Tebbe A; Thill M; Kümmel S; Grischke EM; Richter R; Seite S; Lüftner D
    Breast Cancer (Dove Med Press); 2014; 6():115-22. PubMed ID: 25114589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings.
    Cowdell F; Jadotte YT; Ersser SJ; Danby S; Lawton S; Roberts A; Dyson J
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011377. PubMed ID: 32006460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.
    Ward S; Simpson E; Davis S; Hind D; Rees A; Wilkinson A
    Health Technol Assess; 2007 Oct; 11(40):1-144. PubMed ID: 17903394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.
    Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF
    Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer.
    Rašić A; Sofić A; Bešlija S; Rašić I; Hasanbegović B
    Med Glas (Zenica); 2019 Feb; 16(1):77-82. PubMed ID: 30256061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxanes for adjuvant treatment of early breast cancer.
    Ferguson T; Wilcken N; Vagg R; Ghersi D; Nowak AK
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004421. PubMed ID: 17943815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study.
    Dalenc F; Ribet V; Rossi AB; Guyonnaud J; Bernard-Marty C; de Lafontan B; Salas S; Ranc Royo AL; Sarda C; Levasseur N; Massabeau C; Levecq JM; Dulguerova P; Guerrero D; Sibaud V
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28833787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.
    Kirkham AA; Paterson DI; Prado CM; Mackey JR; Courneya KS; Pituskin E; Thompson RB
    BMC Cancer; 2018 Sep; 18(1):864. PubMed ID: 30176834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of taxane and anthracycline combination regimens in the management of advanced breast cancer: a meta-analysis of randomized trials.
    Zheng R; Han S; Duan C; Chen K; You Z; Jia J; Lin S; Liang L; Liu A; Long H; Wang S
    Medicine (Baltimore); 2015 May; 94(17):e803. PubMed ID: 25929935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study.
    Beuth J; Ost B; Pakdaman A; Rethfeldt E; Bock PR; Hanisch J; Schneider B
    Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S45-54. PubMed ID: 11561873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy.
    Hilaj E; Ymeri A; Shpati KP
    Cureus; 2020 Feb; 12(2):e7117. PubMed ID: 32257663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.